【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & Growth Prospect Mapping
4.5. SWOT Analysis, By Factor
4.5.1. Political
4.5.2. Economic
4.5.3. Technological
4.6. Industry Analysis – Porter’s
4.7. Competitive Landscape & Market Share Analysis, 2015 & 2030
4.8. Liquid Biopsy Pipeline Analysis, 2015 – 2020
Chapter 5. Market Categorization 1: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2015, 2020 & 2030
5.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following applications:
5.2.1. Therapy Selection for Metastatic Breast Cancer (MBS)
5.2.2. Therapy Selection for Other Metastatic Cancer
5.2.3. Molecular Health Monitoring
Chapter 6. Market Categorization 2: Sample Type Estimates & Trend Analysis
6.1. Sample Type Movement Analysis & Market Share, 2015, 2020 & 2030
6.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following sample types:
6.2.1. Blood Samples
6.2.2. Urine Samples
6.2.3. Other Bio fluids (Tissue fluids and Saliva)
Chapter 7. Market Categorization 3: Biomarker Estimates & Trend Analysis
7.1. Biomarker Movement Analysis & Market Share, 2015, 2020 & 2030
7.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following biomarkers:
7.2.1. Circulating Tumor Cells (CTC)
7.2.2. Circulating Tumor DNA (ctDNA)
7.2.3. Exosomes (Macrovesicles with Protein, RNA, DNA)
Chapter 8. Market Categorization 4: Technology Estimates & Trend Analysis
8.1. Technology Movement Analysis & Market Share, 2015, 2020 & 2030
8.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following technologies:
8.2.1. Multi-gene parallel Analysis using NGS
8.2.2. Single Gene Analysis using PCR Microarrays
Chapter 9. Market Categorization 3: Regional Estimates & Trend Analysis
9.1. Regional Movement Analysis & Market Share, 2015, 2020 & 2030
9.2. North America
9.2.1. North America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. North America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.2.2.1. U.S.
9.2.2.2. Canada
9.2.3. North America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.2.3.1. U.S.
9.2.3.2. Canada
9.2.4. North America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.2.4.1. U.S.
9.2.4.2. Canada
9.3. Europe
9.3.1. Europe revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.3.1.1. Germany
9.3.1.2. UK
9.3.2. Europe revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.3.2.1. Germany
9.3.2.2. UK
9.3.3. Europe revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.3.3.1. Germany
9.3.3.2. UK
9.3.4. Europe revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.3.4.1. Germany
9.3.4.2. UK
9.4. Asia Pacific
9.4.1. Asia Pacific revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.4.1.1. Japan
9.4.1.2. China
9.4.2. Asia Pacific revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.4.2.1. Japan
9.4.2.2. China
9.4.3. Asia Pacific revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.4.3.1. Japan
9.4.3.2. China
9.4.4. Asia Pacific revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.4.4.1. Japan
9.4.4.2. China
9.5. Latin America
9.5.1. Latin America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.5.1.1. Brazil
9.5.2. Latin America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.5.2.1. Brazil
9.5.3. Latin America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.5.3.1. Brazil
9.5.4. Latin America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.5.4.1. Brazil
9.6. Middle East & Africa
9.6.1. Middle East & Africa revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.6.1.1. South Africa
9.6.2. Middle East & Africa revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.6.2.1. South Africa
9.6.3. Middle East & Africa revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.6.3.1. South Africa
9.6.4. Middle East & Africa revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.6.4.1. South Africa
Chapter 10. Competitive Landscape
10.1. Adaptive Biotechnologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Biocept
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Guardant Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. NeoGenomics Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Personal Genome Diagnostics
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Qiagen
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. RainDance Technologies
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Trovagene
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Cynvenio
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Epic Sciences
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
10.11. Exosome
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Strategic Initiatives
10.12. Foundation Medicine
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Strategic Initiatives
10.13. Genomic Health
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Strategic Initiatives
10.14. Illumina Inc.
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.4. Strategic Initiatives
10.15. Angle Plc
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Strategic Initiatives
10.16. Boreal Genomics
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Strategic Initiatives
10.17. CareDx
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Strategic Initiatives
10.18. Chronix Biomedical
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Strategic Initiatives
10.19. Cynvenio Biosystems Inc.
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Strategic Initiatives
10.20. Epic Sciences
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Strategic Initiatives
10.21. Foundation Medicine
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. Product Benchmarking
10.21.4. Strategic Initiatives
10.22. Natera Inc.
10.22.1. Company Overview
10.22.2. Financial Performance
10.22.3. Product Benchmarking
10.22.4. Strategic Initiatives
10.23. Pathway Genomics
10.23.1. Company Overview
10.23.2. Financial Performance
10.23.3. Product Benchmarking
10.23.4. Strategic Initiatives
10.24. Roche (Ariosa)
10.24.1. Company Overview
10.24.2. Financial Performance
10.24.3. Product Benchmarking
10.24.4. Strategic Initiatives
10.25. Sequenom
10.25.1. Company Overview
10.25.2. Financial Performance
10.25.3. Product Benchmarking
10.25.4. Strategic Initiatives
10.26. Trovagene
10.26.1. Company Overview
10.26.2. Financial Performance
10.26.3. Product Benchmarking
10.26.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：液体生検の世界市場分析：用途別（転移性乳がん（MBS）の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング）、サンプル別（血液、尿、組織および唾液）、バイオマーカー別（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、エキソソーム）、技術別（単一遺伝子解析（PCRマイクロアレイ）、多遺伝子並列分析（NGS））、動向分析、2013-2030■ 英文：Liquid Biopsy Market Size & Forecast By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) And Trend Analysis from 2013 To 2030
■ 発行日：2016年9月8日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707486
■ 調査対象地域：グローバル
- 交通管理の世界市場予測（～2023年）Factors such as high demographic growth and hyper-urbanization in the developing countries and the government initiatives for traffic management under smart cities models are some of the factors driving the traffic management marketThe traffic management market is expected to grow from USD 26.7 billion in 2018 to USD 50.7 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 13.7%. The marke …
- 道路輸送燃料の世界市場2019-2023About this market The rising urbanization and industrialization are one of the key factors expected to trigger the road transportation fuel market growth during the forecast period. Urban growth and transportation are often related to each other as urban population growth increases demand for travel, while urban development encompasses the development of transportation infrastructure. Furthermore, …
- Denbury Resources Inc.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Denbury Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Denbury Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界の強誘電性ＲＡＭ市場動向（2012-2016）TechNavio's analysts forecast the Global Ferroelectric RAM market to grow at a CAGR of 18.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high demand in wireless applications. The Global Ferroelectric RAM market has also been witnessing the increased investment in R&D. However, the time to market pressure could pose a challenge to the growth of …
- ヨーロッパのPOCT（POC検査）市場2015-2019About POCT Market in Europe POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The h …
- デジタル資産管理（DAM）サービスの世界市場：ウェブコンテンツ管理、デジタルコンテンツ管理About Digital Asset Management Digital asset management is a business process that organizes, stores, and retrieves rich media content, apart from managing digital rights and permissions. Rich media assets include music, videos, photos, animations, podcasts, and other multimedia content. It consists of management tasks and decisions surrounding the ingestion, cataloging, storage, retrieval, and di …
- Nexen Energy ULC：石油・ガスの開発・生産動向及びコスト分析- 2012Nexen Energy ULC Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Nexen Energy ULC Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key opera …
- 乾性角結膜炎(ドライアイ)：世界の治験レビュー（2015年上半期版）Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dr …
- 次世代アビオニクス（航空機用電子機器）の世界市場2015-2019About nextgen avionics Next-generation avionics are electronic equipment incorporated in aircraft to help pilots maneuver efficiently. They include communication systems, autopilot systems, sensors, transponders, flight management systems, navigational systems, displays, and anti-collision systems. The next-generation avionics market is heavily influenced by the number of operational aircraft. The …
- Leprosy：グローバル臨床試験レビューH2, 2013Leprosy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Leprosy Global Clinical Trials Review, H2, 2013" provides data on the Leprosy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leprosy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- 神経調節の世界市場：製品別、地域別Global Neuromodulation Market: About this market Technavio’s neuromodulation market analysis considers sales from implantable neuromodulation devices and external neuromodulation devices. Our study also finds the sales of neuromodulation in Asia, Europe, North America, and ROW. In 2019, the implantable neuromodulation devices segment had a significant market share, and this trend is expected to co …
- サービスとしての調達の世界市場予測（～2024年）The growing demand to improve procurement operations and need to reduce the cost associated with procurement among the organizations to drive the market growth The global procurement as a service market size is expected to grow from USD 5.4 billion in 2019 to USD 7.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period. The procurement as a service market is …
- 公衆安全およびセキュリティソリューションの世界市場予測：クリティカル通信ネットワーク、バイオメトリクス、認証システム、監視システム、緊急事態・災害管理、サイバーセキュリティThe public safety and security market size is expected to grow from USD 247.53 Billion in 2016 to USD 456.56 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period. The major growth drivers of the market include rise in criminal activities, natural disaster & cross border terrorism, need for stringent government policies & regulations for public safety, and in …
- 高機能顔料（HPP）の世界市場予測：有機、無機、ハイブリッド“The HPPs market is projected to register a CAGR of 4.3% during the forecast period.”The HPPs market size is projected to grow from USD 5.2 billion in 2019 to USD 6.4 billion by 2024, at a CAGR of 4.3% between 2019 and 2024. The growing number of commute vehicles in roadways, airways and waterways and growth in construction & infrastructure buildings is driving the growth of the HPPs industry. The …
- 航空機内装用接着剤の世界市場予測（～2021年）：IFE、シート、荷物置き場、ギャレー、パネル“The global aerospace interior adhesives market is projected to grow at a CAGR of 5.35% from 2016 to 2021”The global aerospace interior adhesive market is projected to reach USD 1,101.7 million by 2021, at a CAGR of 5.35% from 2016 to 2021. The growing middle class and increasing disposable income as well as growing demand of low cost airlines are major factors expected to drive the growth of the …
